DIPEXIUM PHARMACEUTICALS INC's ticker is DPRX and the CUSIP is 25456J104. A total of 32 filers reported holding DIPEXIUM PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2016 | $3,449,000 | +46.3% | 237,874 | 0.0% | 0.07% | +48.9% |
| Q2 2016 | $2,357,000 | -31.7% | 237,874 | -34.4% | 0.05% | -36.5% |
| Q1 2016 | $3,451,000 | -61.1% | 362,874 | -54.2% | 0.07% | -62.8% |
| Q4 2015 | $8,869,000 | -19.4% | 791,856 | +0.8% | 0.20% | -30.9% |
| Q3 2015 | $10,999,000 | +33.0% | 785,615 | +20.9% | 0.29% | +60.0% |
| Q2 2015 | $8,268,000 | – | 650,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lone Star Value Management LLC | 95,000 | $1,330,000 | 2.54% |
| Timpani Capital Management LLC | 134,716 | $1,886,000 | 0.76% |
| KINGDON CAPITAL MANAGEMENT, L.L.C. | 981,100 | $13,735,000 | 0.66% |
| 1492 Capital Management LLC | 38,000 | $532,000 | 0.38% |
| Broadfin Capital, LLC | 465,978 | $6,524,000 | 0.36% |
| Tourbillon Capital Partners, L.P. | 785,615 | $10,999,000 | 0.29% |
| ARDSLEY ADVISORY PARTNERS LP | 45,000 | $630,000 | 0.15% |
| 683 Capital Management, LLC | 70,000 | $980,000 | 0.14% |
| BOOTHBAY FUND MANAGEMENT, LLC | 18,043 | $253,000 | 0.12% |
| FALCON POINT CAPITAL, LLC | 22,570 | $316,000 | 0.11% |